These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7726126)
21. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. Gill JB; Cairns JA; Roberts RS; Costantini L; Sealey BJ; Fallen EF; Tomlinson CW; Gent M N Engl J Med; 1996 Jan; 334(2):65-70. PubMed ID: 8531960 [TBL] [Abstract][Full Text] [Related]
22. Left ventricular dysfunction following transient ischaemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischaemic myocardial stunning. Sheiban I; Tonni S; Benussi P; Marini A; Trevi GP Eur Heart J; 1993 Jul; 14 Suppl A():14-21. PubMed ID: 8370356 [TBL] [Abstract][Full Text] [Related]
23. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy. Belardinelli R Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102 [TBL] [Abstract][Full Text] [Related]
24. Ventricular function and calcium handling during ischemia. Amende I; Bentivegna L; Morgan JP J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S42. PubMed ID: 1282612 [TBL] [Abstract][Full Text] [Related]
25. Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction. Rousseau MF; Melin J; Benedict CR; Ahn S; Raphaël D; Bornemann M; Pouleur H Eur Heart J; 1994 Jul; 15(7):957-64. PubMed ID: 7925518 [TBL] [Abstract][Full Text] [Related]
26. Additive effects of age and silent myocardial ischemia on the left ventricular response to upright cycle exercise. Fleg JL; Schulman SP; Gerstenblith G; Becker LC; O'Connor FC; Lakatta EG J Appl Physiol (1985); 1993 Aug; 75(2):499-504. PubMed ID: 8226445 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of transient myocardial ischaemia after first acute myocardial infarction: five year follow up study. Mickley H; Nielsen JR; Berning J; Junker A; Møller M Br Heart J; 1995 Apr; 73(4):320-6. PubMed ID: 7756064 [TBL] [Abstract][Full Text] [Related]
28. Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease. Fodor JG Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():873-9. PubMed ID: 9126676 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences]. Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641 [TBL] [Abstract][Full Text] [Related]
30. Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II Study. The DEFIANT-II Research Group. Eur Heart J; 1997 Jan; 18(1):31-40. PubMed ID: 9049513 [TBL] [Abstract][Full Text] [Related]
31. Transient myocardial ischemia after myocardial infarction. Mickley H Cardiology; 1995; 86(1):8-14. PubMed ID: 7728794 [TBL] [Abstract][Full Text] [Related]
32. The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia. Ehring T; Böhm M; Heusch G J Cardiovasc Pharmacol; 1992 Jul; 20(1):63-74. PubMed ID: 1383632 [TBL] [Abstract][Full Text] [Related]
33. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. Park SW; Tang XL; Qiu Y; Sun JZ; Bolli R J Mol Cell Cardiol; 1996 Apr; 28(4):655-66. PubMed ID: 8732494 [TBL] [Abstract][Full Text] [Related]
34. [Exertion-induced myocardial ischemia has little influence on ventricular remodeling in post-infarction patients with preserved systolic function]. Temporelli PL; Corrå U; Marcassa C; Galli M; Imparato A; Giannuzzi P G Ital Cardiol; 1996 Jul; 26(7):729-37. PubMed ID: 8964315 [TBL] [Abstract][Full Text] [Related]
35. Silent ischemia and loss of reversible myocardial dysfunction following myocardial infarction. Scognamiglio R; Fasoli G; Nistri S; Miorelli M; Frigato N; Palisi M; Miraglia G; Dalla-Volta S Clin Cardiol; 1993 Sep; 16(9):654-9. PubMed ID: 8242909 [TBL] [Abstract][Full Text] [Related]
36. Effect of calcium antagonists on exercise tests. Lai C; Cherchi A; Onnis E; Solinas R; Lai G; Cherchi PA J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S55-64. PubMed ID: 1282616 [TBL] [Abstract][Full Text] [Related]
37. Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease. Sheiban I; Tonni S; Marini A; Trevi G Am J Cardiol; 1995 Apr; 75(13):23E-30E. PubMed ID: 7726120 [TBL] [Abstract][Full Text] [Related]
38. Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance. Bolognese L; Rossi L; Sarasso G; Prando MD; Bongo AS; Dellavesa P; Rossi P J Am Coll Cardiol; 1992 Apr; 19(5):953-9. PubMed ID: 1552118 [TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction. Wilson J; Commerford PJ; Millar RS; Opie LH Cardiovasc Drugs Ther; 1992 Feb; 6(1):41-6. PubMed ID: 1576095 [TBL] [Abstract][Full Text] [Related]
40. Metoprolol abolishes exercise-induced left ventricular dysfunction in patients with silent ischemia. Bech J; Madsen JK; Kelbaek H; Hvid-Jacobsen K; Skagen K Am J Cardiol; 1996 Oct; 78(8):871-5. PubMed ID: 8888657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]